Aggrecanase. A target for the design of inhibitors of cartilage degradation

Annals of the New York Academy of Sciences

Volumn 878, Issue , 1999, Pages 92-107

  Arner, Elizabeth C ^a   Pratta, Michael A ^a   Decicco, Carl P ^a   Xue, Chu Biao ^a   Newton, Robert C ^a   Trzaskos, James M ^a   Magolda, Ronald L ^a   Tortorella, Micky D ^a  

^a DUPONT COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGGRECAN; INTERLEUKIN 1; PROTEINASE;

ANIMAL TISSUE; ARTHRITIS; CARTILAGE DEGENERATION; CATTLE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG TARGETING; NONHUMAN; NOSE CARTILAGE; PROTEIN DEGRADATION; PROTEIN DOMAIN; SEQUENCE ANALYSIS;

ANIMALIA; BOS TAURUS; BOVINAE;

EID: 0032837711     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1999.tb07676.x     Document Type: Conference Paper

References (31)

1. 1. Mankin, H.J. & L. Lippiello. 1970. Biochemical and metabolic abnormalities in articular cartilage from osteo-arthritic human hips J. Bone Joint Surg. 52A: 424-434.
2. 2. Morales, T.I. & V.C. Hascall. 1989. Factors involved in the regulation of proteoglycan metabolism in articular cartilage. Arthritis Rheum 32(10): 1197-1201.
3. 3. Tyler, J.A. 1985. Chondrocyte-mediated depletion of articular cartilage proteoglycans in vitro. Biochem. J. 225: 493-507.
4. 4. Ilic, M.Z., C.J. Handley, H.C. Robinson & M.T. Mok. 1992. Mechanism of catabolism of aggrecan by articular cartilage. Arch. Biochem. Biophys. 294(1): 115-22.
5. 5. Loulakis, P., A. Shrikhande, G. Davis & C.A. Maniglia. 1992. N-terminal sequence of proteoglycan fragments isolated from medium of interleukin-1-treated articular-cartilage cultures. Putative site(s) of enzymic cleavage. Biochem. J. 284: 589-593.
6. 6. Sandy, J.D., A.H.K. Plaas & T.J. Koob. 1995. Pathways of aggrecan processing in joint tissues. Implications for disease mechanism and monitoring. Acta Orthop. Scand. (Suppl 266) 66: 26-32.
7. 7. Lark, M.W., J.T. Gordy, J.R, Weidner, J. Ayaia, J.H. Kimura, H.R. Williams, R.A. Mumford, C.R. Flannery, S.S. Carisoni, M. Iwatai & J.D. Sandy. 1995. Cell-mediated catabolism of aggrecan. Evidence that cleavage at the "aggrecanase" site (Glu373-Ala374) is a primary event in proteolysis of the interglobular domain. J. Biol. Chem. 270: 2550-2556.
8. 8. Flannery, C.R., M.W. Lark & D. Sandy. 1992. Identification of a stromelysin cleavage site within the interglobular domain of human aggrecan. Evidence for proteolysis at this site in vivo in human articular cartilage. J. Biol. Chem. 267: 1008-1014.
9. 9. Fosang, A.J., P.J. Neame, K. Last, T.E. Hardhingham, G. Murphy & J.A. Hamilton. 1992. The interglobular domain of cartilage aggrecan is cleaved by PUMP, gelatinases, and cathepsin B. J. Biol. Chem. 267: 19470-19474.
10. 10. Fosang, A.J., K. Last, V. Knauper, P.J. Neame, G. Murphy, T.E. Hardingham, H. Tschesche & J.A. Hamilton. 1993. Fibroblast and neutrophil collagenases cleave at two sites in the cartilage aggrecan interglobular domain. Biochem. J. 295: 273-276.
11. 11. Fosang, A.J., K. Last, V. Knauper, G. Murphy & P.J. Neame. 1996. Degradation of cartilage aggrecan by collagenase-3 (MMP-13). FEBS Lett 380: 17-20.
12. 12. Lohmander, L.S., P.J. Neame & J.D. Sandy. 1993. The structure of aggrecan fragments in human synovial fluid. Evidence that aggreeanase mediates cartilage degradation in inflammatory joint disease, joint injury, and osteoarthritis. Arth. Rheum. 36: 1214-1222.
13. 13. Sandy, J.D., C.R. Flannery, P.J. Neame & L.S. Lohmander. 1992. The structure of aggrecan fragments in human synovial fluid. Evidence for the involvement in osteoarthritis of a novel proteinase which cleaves the Glu 373-A1a 374 bond of the interglobular domain. J. Clin. Invest. 69: 1512-1516.
14. 14. Sandy, J.D., R.E. Boynton & C.R. Flannery. 1991. Analysis of the catabolism of aggrecan in cartilage explants by quantitation of peptides from the three globular domains. J. Biol. Chem. 266: 8198-8205.
15. 15. Sandy, J.D., P.J. Neame, P.L. Boynton & C.R. Flannery. 1991. Catabolism of aggrecan in cartilage explants. Identification of a major cleavage site within the interglobular domain. J. Biol. Chem. 266: 8683-8685.
16. 16. Arner, E.C., C.E. Hughes, C.P. Decicco, B. Caterson, M.D. Tortorella. 1998. Cytokine-induced cartilage proteoglycan degradation is mediated by aggrecanase. Osteoarthritis Cart. 6: 214-228.
17. 17. Tortorella, M.D., J.M. Trzaskos & E.C. Arner. 1997. Identification and characterization of an assay which defines the cartilage degrading enzyme, "aggrecanase" [abstract]. Trans. Orthop. Res. Soc. 22: 452.
18. 18. Arner, E.C., M.A. Pratta, J.M. Trzaskos, C.P. Decicco & M.D. Tortorella. 1999. Generation and characterizalion of aggrecanase: a soluble, cartilage-derived aggrecan-degrading activity. J. Biol. Chem. 274: 6594-6601.
19. 19. Huang, J.J., R.C. Newton, K. Pezzella, M. Covington, T. Tamblyn, S.J. Rutledge, M. Kelley, J. Gray & Y. Lin. 1987. High-level expression in Escherichia coli of a soluble and fully active recombinant interleukin-1 beta. Mol. Biol. Med. 4: 169-181.
20. 20. Huches, C.E., B. Caterson, A.J. Fosang, P.J. Roughley & J.S. Mort. 1995. Monoclonal antibodies that specifically recognize neoepitope sequences generated by "aggrecanase" and matrix metalloproteinase cleavage of aggrecan: application to catabolism in situ and in vitro. Biochem. J. 305: 799-804.
21. 21. Xue, C.-B., R.J. Cherney, C.P. DeCicco, W.F. DeGrado, X. He, C.N. Hodge, I.C. Jacobson, R.L. Magolda & E.C. Arner, inventors; DuPont Merck Pharmaceutical Company, assignee. 1997. WO 9718207 A2, May 22.
22. 22. Arner, E.C. & M.A. Pratta. 1991. Modulation of interleukin-1-induced alterations in cartilage metabolism by activation of protein kinase C. Arthritis Rheum. 34: 1006-1013.
23. 23. Farndale, R.W., C.A. Sayers & A.J. Barrett. 1982. A direct spectrophotometric microassay for sulfated glycosaminoglycans cartilage cultures. Connect. Tissue Res. 9; 247-248.
24. 24. Fosang, A.J., K. Last, P. Gardiner, D.C. Jackson & L. Brown. 1995. Development of a cleavage-site-specific monoclonal antibody for detecting metalloproteinase-derived aggrecan fragments: detection of fragments in human synovial fluids. Biochem. J. 310: 337-343.
25. 25. Laemmli, U.K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685.
26. 26. Hughes, C.E., B. Caterson, R.J. White, P.J. Roughley & J.S. Mort. 1992. Monoclonal antibodies recognizing protease-generated neoepitopes from cartilage proteoglycan degradation. Application to studies of human link protein cleavage by stromelysin. J. Biol. Chem. 267: 16011-16014.
27. 27. Tortorella, M.D. & E.C. Arner. 1997. A fluorescent enzyme-linked immunosorbent assay (FELISA) for stromelysin using a polyclonal antisera to human stromelysin with broad cross-reactivity. Inflamm. Res. 46 (Suppl. 2): S120-S121.
28. 28. Tortorella, M.D. & E.C. Arner. 1997. A high-throughput assay for stromelysin using a casein-resorufin substrate. Inflamm. Res. 46 (Suppl. 2): S122-S123.
29. 29. Manicort, D.-H. & V. Lefebvre. 1993. An assay for matrix metalloproteinases and other protcases acting on proteoglycans, casein, or gelatin. Anal. Biochem. 215: 171-179.
30. 30. Vaes, G., Y. Eechout, G. Lenaers-Claeys, C. Francois-Gillet & J.E. Druetz. 1978. The simultaneous release by bone explants in culture and the parallel activation of procollagenase and of a latent neutral proteinase that degrades cartilage proteoglycans and denatured collagen. Biochem. J. 172: 261-274.
31. 31. Pratta, M.A., M.D. Tortorella, R.C. Newton, J.M. Trzaskos, R.L. Magolda, C.P. Decicco, A.A. Cole, B.L. Schumacher, K.E. Keuttner & E.C. Arner. 1998. Aggrecan degradation in interleukin-1-stimulated bovine nasal cartilage explants is up-regulated exclusively by aggrecanase-mediated cleavage [abstract]. Trans. Orthop. Res. Soc. 23: 177.